Recent Analysts’ Ratings Updates for Neogen (NEOG)

A number of research firms have changed their ratings and price targets for Neogen (NASDAQ: NEOG):

  • 4/2/2018 – Neogen was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 3/29/2018 – Neogen was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. “
  • 3/28/2018 – Neogen was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $74.00 price target on the stock. According to Zacks, “Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. “
  • 3/26/2018 – Neogen had its “hold” rating reaffirmed by analysts at Stephens. They now have a $65.00 price target on the stock, up previously from $62.00.
  • 3/15/2018 – Neogen was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 2/16/2018 – Neogen was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 2/15/2018 – Neogen was downgraded by analysts at Zacks Investment Research from a “strong-buy” rating to a “hold” rating. According to Zacks, “Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. “

Shares of NEOG opened at $67.30 on Monday. The company has a market cap of $3,471.54, a price-to-earnings ratio of 78.26, a P/E/G ratio of 3.93 and a beta of 1.27. Neogen has a 52 week low of $44.63 and a 52 week high of $68.69.

How to Become a New Pot Stock Millionaire

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Thursday, March 22nd. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.08. The firm had revenue of $95.90 million during the quarter, compared to analyst estimates of $97.93 million. Neogen had a return on equity of 11.49% and a net margin of 14.82%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.27 EPS. sell-side analysts predict that Neogen will post 1.14 earnings per share for the current fiscal year.

In other Neogen news, CFO Steven J. Quinlan sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $60.15, for a total transaction of $120,300.00. Following the completion of the sale, the chief financial officer now directly owns 15,470 shares of the company’s stock, valued at approximately $930,520.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Steven J. Quinlan sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $66.13, for a total value of $330,650.00. Following the sale, the chief financial officer now directly owns 15,203 shares of the company’s stock, valued at $1,005,374.39. The disclosure for this sale can be found here. Insiders have sold a total of 77,382 shares of company stock valued at $4,645,383 over the last three months. Corporate insiders own 4.20% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Louisiana State Employees Retirement System increased its holdings in Neogen by 5.8% during the 4th quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the company’s stock worth $1,348,000 after purchasing an additional 900 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Neogen by 3.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 33,512 shares of the company’s stock worth $2,596,000 after purchasing an additional 979 shares in the last quarter. Cookson Peirce & Co. Inc. increased its holdings in Neogen by 24.8% during the 4th quarter. Cookson Peirce & Co. Inc. now owns 6,250 shares of the company’s stock worth $514,000 after purchasing an additional 1,240 shares in the last quarter. Thomson Horstmann & Bryant Inc. grew its holdings in shares of Neogen by 7.9% in the fourth quarter. Thomson Horstmann & Bryant Inc. now owns 20,422 shares of the company’s stock valued at $1,678,000 after acquiring an additional 1,491 shares in the last quarter. Finally, Swiss National Bank grew its holdings in shares of Neogen by 2.4% in the fourth quarter. Swiss National Bank now owns 65,150 shares of the company’s stock valued at $5,356,000 after acquiring an additional 1,500 shares in the last quarter. 68.13% of the stock is owned by hedge funds and other institutional investors.

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Somewhat Positive Media Coverage Somewhat Unlikely to Impact Xcel Energy  Share Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Xcel Energy Share Price
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Magna International  Share Price
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Magna International Share Price
Shinhan Financial Group  Receives Daily Coverage Optimism Score of 0.08
Shinhan Financial Group Receives Daily Coverage Optimism Score of 0.08
Somewhat Positive Media Coverage Somewhat Unlikely to Impact KeyCorp  Share Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact KeyCorp Share Price
Alibaba Group  Expected to Announce Earnings of $0.92 Per Share
Alibaba Group Expected to Announce Earnings of $0.92 Per Share
Brokerages Expect Sunoco LP  to Post $0.52 Earnings Per Share
Brokerages Expect Sunoco LP to Post $0.52 Earnings Per Share


Leave a Reply

© 2006-2018 Ticker Report. Google+.